Clinical characteristics of 228 hospitalized patients with COVID-19
Q4 Medicine
T. Wang, S. Gao, X. Bao, J. Bian
{"title":"Clinical characteristics of 228 hospitalized patients with COVID-19","authors":"T. Wang, S. Gao, X. Bao, J. Bian","doi":"10.14188/j.1671-8852.2020.0474","DOIUrl":null,"url":null,"abstract":"Objective: To describe the epidemiological and clinical features of coronavious disease 2019 (COVID-19). Methods: The data of 228 inpatients diagnosed as COVID-19 in the Third Hospital of Wuhan from January 27, 2020, to February 29, 2020 were collected, and their clinical characteristics and outcomes were analyzed. Results: The average age of inpatients was 58 years old. Common symptoms included fever (88.2%), fatigue (69.7%), and dry cough (59.2%). There were patients with gastrointestinal discomfort as the first symptom (7.9%). In severe patients, lymphocytes decreased significantly, albumin decreased, D-dimer increased, lactate dehydrogenase and creatine kinase isoenzyme increased (all P <0.05). Chest CT of all patients showed patchy shadows or frosted glass opacity of both lungs. Severe patients were more likely to have comorbidities ( P <0.05), and more likely to have complications including acute respiratory distress syndrome (ARDS) (19 cases, 8.3%), arrhythmia (13 cases, 5.7%), and shock (5 cases, 2.2%), and 7% COVID⁃19 cases were transferred to the ICU due to the worsening of the disease, and the patients' mortality rate was 4.4%. There were no specific drugs for treatment, and supportive treatment was the mainstay. Conclusion: Severe patients had differences in age of onset, underlying diseases, symptoms, laboratory tests, and complications, etc., and needed to be identified earlier. © 2021, Editorial Board of Medical Journal of Wuhan University. All right reserved.","PeriodicalId":35402,"journal":{"name":"武汉大学学报(医学版)","volume":"42 1","pages":"709-713"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"武汉大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14188/j.1671-8852.2020.0474","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To describe the epidemiological and clinical features of coronavious disease 2019 (COVID-19). Methods: The data of 228 inpatients diagnosed as COVID-19 in the Third Hospital of Wuhan from January 27, 2020, to February 29, 2020 were collected, and their clinical characteristics and outcomes were analyzed. Results: The average age of inpatients was 58 years old. Common symptoms included fever (88.2%), fatigue (69.7%), and dry cough (59.2%). There were patients with gastrointestinal discomfort as the first symptom (7.9%). In severe patients, lymphocytes decreased significantly, albumin decreased, D-dimer increased, lactate dehydrogenase and creatine kinase isoenzyme increased (all P <0.05). Chest CT of all patients showed patchy shadows or frosted glass opacity of both lungs. Severe patients were more likely to have comorbidities ( P <0.05), and more likely to have complications including acute respiratory distress syndrome (ARDS) (19 cases, 8.3%), arrhythmia (13 cases, 5.7%), and shock (5 cases, 2.2%), and 7% COVID⁃19 cases were transferred to the ICU due to the worsening of the disease, and the patients' mortality rate was 4.4%. There were no specific drugs for treatment, and supportive treatment was the mainstay. Conclusion: Severe patients had differences in age of onset, underlying diseases, symptoms, laboratory tests, and complications, etc., and needed to be identified earlier. © 2021, Editorial Board of Medical Journal of Wuhan University. All right reserved.
228例新冠肺炎住院患者临床特征分析
目的:了解2019冠状病毒病(COVID-19)的流行病学和临床特征。方法:收集武汉市第三医院2020年1月27日至2020年2月29日228例确诊为COVID-19的住院患者资料,分析其临床特征及转诊结果。结果:住院患者平均年龄58岁。常见症状包括发热(88.2%)、疲劳(69.7%)和干咳(59.2%)。以胃肠道不适为首发症状的患者占7.9%。重症患者淋巴细胞明显减少,白蛋白减少,d -二聚体升高,乳酸脱氢酶和肌酸激酶同工酶升高(均P <0.05)。所有患者胸部CT均显示双肺斑片状影或磨砂玻璃影。重症患者合并症发生率较高(P <0.05),出现急性呼吸窘迫综合征(ARDS)(19例,8.3%)、心律失常(13例,5.7%)、休克(5例,2.2%)等并发症的发生率较高,7%的COVID⁃19患者因病情恶化转入ICU,病死率为4.4%。无特效药治疗,以支持治疗为主。结论:重症患者在发病年龄、基础疾病、症状、实验室检查、并发症等方面存在差异,需及早发现。©2021,武汉大学医学杂志编辑委员会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。